|
注册号: Registration number: |
ChiCTR2000036307 |
|
最近更新日期: Date of Last Refreshed on: |
2020-09-06 06:18:33 |
|
注册时间: Date of Registration: |
2020-08-22 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
ERAS在门诊无痛胃肠镜中的应用 |
|
Public title: |
The application of ERAS in outpatient painless gastroenteroscopy |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
ERAS在门诊无痛胃肠镜中的应用 |
|
Scientific title: |
The application of ERAS in outpatient painless gastroenteroscopy |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
谭成维 |
研究负责人: |
朱昭琼 |
|
Applicant: |
Tan Chengwei |
Study leader: |
Zhu Zhaoqiong |
|
申请注册联系人电话: Applicant telephone: |
+86 18198632008 |
研究负责人电话:
Study leader's |
+86 13035529980 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
308729693@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
zmctcw@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
贵州省遵义市汇川区大连路149号 |
研究负责人通讯地址: |
贵州省遵义市汇川区大连路149号 |
|
Applicant address: |
149 Dalian Road, Huichuan District, Zunyi, Guizhou, China |
Study leader's address: |
149 Dalian Road, Huichuan District, Zunyi, Guizhou, China |
|
申请注册联系人邮政编码: Applicant postcode: |
563000 |
研究负责人邮政编码: Study leader's postcode: |
563000 |
|
申请人所在单位: |
遵义医科大学 |
||
|
Applicant's institution: |
Zunyi Medical University |
||
|
研究负责人所在单位: |
遵义医科大学 |
||
|
Affiliation of the Leader: |
Zunyi Medical University |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
KLLY-2019-107 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
遵义医学院附属医院生物医学研究伦理委员会 |
||
|
Name of the ethic committee: |
Biomedical Research Ethics Committee of Affiliated Hospital of Zunyi Medical College |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2019-12-02 00:00:00 | ||
|
伦理委员会联系人: |
郑洪 |
||
|
Contact Name of the ethic committee: |
Zheng hong |
||
|
伦理委员会联系地址: |
贵州省遵义市汇川区大连路遵义医科大学行政楼 |
||
|
Contact Address of the ethic committee: |
Administrative Building, Zunyi Medical University, 149 Dalian Road, Huichuan District, Zunyi, Guizhou, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
||
|
研究实施负责(组长)单位: |
遵义医科大学附属医院麻醉科 |
||||||||||||||||||||||
|
Primary sponsor: |
Department of Anesthesiology, Affiliated Hospital of Zunyi Medical University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
贵州省遵义市汇川区大连路149号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
149 Dalian Road, Huichuan District, Zunyi, Guizhou, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
自筹 |
||||||||||||||||||||||
|
Source(s) of funding: |
self-raised |
||||||||||||||||||||||
|
研究疾病: |
胃肠道疾病 |
||||||||||||||||||||||
|
Target disease: |
Gastrointestinal disease |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
探索性研究/预试验 | ||||||||||||||||||||||
|
Study phase: |
0 |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
(1)通过对无痛精查胃镜患者检查术前2h口服碳水化合物的临床观察,明确无痛精查患者术前2小时口服碳水化合物的安全性和有效性; (2)了解我院无痛精查胃镜现状,掌握我院无痛精查胃镜需要改进的环节,为精查胃镜术前补液提供理论依据,以期将麻醉镇静技术ERAS安全的理念更好的应用到精查胃镜中。 |
||||||||||||||||||||||
|
Objectives of Study: |
(1) The safety and efficacy of oral carbohydrates 2 hours before the operation of painless fine examination of gastroscopy in patients were determined through clinical observation of oral carbohydrates 2 hours before the operation of painless fine examination; (2) To understand the current situation of painless fine examination gastroscopy in our hospital, and to grasp the links that need to be improved, so as to provide theoretical basis for preoperative fluid replacement in fine examination gastroscopy, and to better apply the concept of ERAS safety from anesthesia sedation technology to fine examination gastroscopy. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
1、不同意加入该课题研究、依从性差、无法配合随访的患者; |
||||||||||||||||||||||
|
Exclusion criteria: |
1. Patients who do not agree to join the study, have poor compliance and cannot cooperate with follow-up; |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2020-08-19 00:00:00至 To 2020-12-01 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2020-08-19 00:00:00 至 To 2020-12-01 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
随机数字表法 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
Random number table method |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
未说明 |
|
Blinding: |
Not stated |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
2021年6月 邮箱 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
June 2021 Email address |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
病例记录表 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Case Record Form |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |